A previous donor intervention trial found that therapeutic hypothermia reduced delayed graft function (DGF) after kidney transplantation. This retrospective cohort study nested in the randomized dopamine trial (ClinicalTrials.gov identifier: NCT000115115) investigates the effects of spontaneous donor hypothermia (core body temperature <36°C) on initial kidney graft function, and evaluates 5-year graft 
delayed graft function (DGF) after kidney transplantation. However, data on graft survival are not yet available, and the underlying molecular mechanisms remain unrevealed. 7 The present cohort study nested in the prospective database of the randomized dopamine trial CBT was measured at least twice daily on a routine basis. In the present study, we used the last single measurement in the ICU assessed 4-20 hours before procurement.
The protocol of the dopamine trial was approved by the
Institutional Review Board of the Medical Faculty of Mannheim and passed the organ-specific Advisory Committees of the Eurotransplant
International Foundation, Leiden, The Netherlands, before enrollment of donors. All patients on the waiting list consented the use of pseudonymized medical data for external quality assessments and scientific analyses.
| Statistical analysis
Statistical analyses were carried out in the database of the dopamine trial. Donors and respective transplant recipients were grouped according to the cut-point of 36.0°C for the donor's CBT. We compared quantitative data with 2-sample t tests, and applied the Mann-Whitney U test when data were not normally distributed. Qualitative data were analyzed with Fisher exact tests. We estimated graft survival according to the Kaplan-Meier method and used log rank tests to compare survival between groups. A P value of <.05 was considered significant.
Linear regression was applied to explore putative donor factors that may have affected serum creatinine in the DBD before procurement. We examined CBT, age, gender, body mass index (BMI), mean arterial pressure, 24-hour urine production, cause of BD, time spent in ICU, and dopamine infusion time as independent determinants of serum creatinine.
Regression coefficients are presented with 95% confidence intervals (CI).
We used logistic regression to evaluate the primary trial endpoint and performed Cox regression to assess 5-year kidney graft survival.
To control for possible confounding influences, we added age and gender of donors and recipients, donor mean arterial blood pressure, serum creatinine and 24-hour urine production, prevalent donor hy- 
| RESULTS

| Donor characteristics
All 264 donors who met the eligibility criteria for trial enrollment were grouped by occurrence of spontaneous hypothermia (CBT <36.0°C).
Accordingly, we assigned 54 donors to hypothermia and 210 to controls. Mean CBT was 35.2 ± 0.8°C and 36.8 ± 0.7°C in the hypothermia and nonhypothermia group, respectively. Donors were similar in both study groups with the exception that hypothermic donors had a lower serum creatinine on the day of procurement. The difference just missed the level of significance (Table 1) .
| Determinants of serum creatinine in the DBD
Although the last recorded serum creatinine values were largely within the normal range, kidney function appeared linked to CBT in the DBD (Figure 1 ). Linear regression confirmed this association in the multivariable analysis. Apart from CBT, gender, BMI, and time spent in the ICU were significant determinants of serum creatinine, whereas age, blood pressure, 24-hour urine production, and cause of BD were not. Notably, dopamine did not affect serum creatinine (Table 2) .
Neither dopamine infusion time (P = .31) nor length of stay in the ICU (P = .28) correlated with CBT. 
| Study flow
| Recipient demographics and corresponding donor/transplant characteristics
Recipients of the hypothermia group were a little older (54.4 vs 51.9 years; P = .07). F I G U R E 1 Regression of donor serum creatinine on core body temperature. Dotted lines reflect 2 times the standard error of residuals
Regression of serum creatinine (recorded on the day of organ procurement) and donor characteristics T A B L E 3 Recipient demographics with corresponding donor and transplant characteristics, and outcomes according to spontaneous donor hypothermia before procurement were enhanced in recipients of the >1 dialysis group (Table 4) . T (Table 5 ). Donor creatinine before procurement was not a significant variable. This also applied to the underlying causes of death. Irrespective of hypothermia, dopamine infusion time remained an independent factor of reduced dialysis requirement (Table 5 ). Backward stepwise logistic regression reconfirmed all significant terms (Table 6 ). Implementing the KDPI score instead of donor age, gender, serum creatinine, BMI, hypertension/diabetes, and cause of BD for multivariable logistic regression resulted in a highly significant OR of 1.02 (95% CI 1.01-1.03; P < .001), but the independent effect of hypothermia was sustained (OR 0.40, 95% CI 0.22-0.71; P = .002). (Table 7) . 
| Effect of donor hypothermia on DGF
A B L E 3 (Continued) T A B L E 4 Recipient demographics with corresponding donor and transplant characteristics, and outcomes according to dialysis requirement
| Effect of hypothermia on kidney graft survival
T A B L E 4 (Continued)
| DISCUSSION
This study adds to a previous controlled intervention trial of therapeutic hypothermia in the DBD. 7 Different from that trial, the present study investigates the effects of spontaneous hypothermia on DGF and evaluates kidney graft survival. The principal findings are the following: Spontaneous hypothermia as assessed by singular temperature readings in the ICU 4-20 hours before procurement was associated with reductions in DGF after kidney transplantation. The effect was comparable to the reported OR of DGF in the intervention trial. 7 Comparisons at baseline revealed that our donors were on average 5 years older with predominantly female gender (53% vs 37%).
They had a 10% lower BMI and a lower serum creatinine (0.83 mg/dL versus 1.1 mg/dL), but were similar regarding the proportion of expanded-criteria donors, the KDPI score, and the management goals for circulatory stability, including a restrictive use of low-dose vasopressor support. Despite a considerable impact on DGF, our study failed to show a significant graft survival advantage. Hypothermia is a common feature of BD due to decoupling of the lower brain stem where the nerve centers for perception and regulation of CBT are located. Apart from impaired thermoregulation, BD comprises a systemic inflammatory state. 1,2 CBT at least in part may serve as a surrogate of BD-induced subsequent harm in peripheral organs. The statistical association of donor serum creatinine and CBT (Table 2 ) supports this notion and may reflect acute kidney injury (AKI)
T A B L E 5 Logistic regression of multiple dialysis requirement (>1 dialysis session) during the first wk after transplantation
arising from BD-induced inflammation.
DGF is the common pathway of various injurious events during the transplantation process. 8 According to the large registry-based outcome studies, DGF is an important risk factor for graft failure, 9, 10 but the different underlying causes have a varying impact on the ultimate prognosis of the kidney graft. Although donation after circulatory death (DCD) is associated with significantly higher incidences of DGF, midterm survival of DCD kidneys is comparable to those from DBD. [11] [12] [13] There is accumulating evidence that AKI occurring under warm circulatory conditions in the DBD, and progressing to DGF after transplantation hardly worsens midterm graft outcomes. 14-16 A large register-based study from the United Kingdom reported a 2% reduction only in 1-year kidney graft survival from donors with AKI. 17 Our observational study failed to show a significant association of spontaneous hypothermia and graft survival (Tables 3 and 7) . It is possible that harm from inflammation arising in the DBD under stable circulatory conditions will not ameliorate graft survival because of its benign character with spontaneous remission after transplantation.
By contrast, harm from cold storage may exert a more detrimental impact, particularly in the elderly population. According to the Australian and New Zealand Dialysis and Transplant Registry, a significant interaction exists between total ischemic time, donor age, and graft loss. 18 Furthermore, in recipients from live donors aged >50 years, CIT was associated with increased odds for DGF, and increased hazards for overall and death-censored graft loss, when CIT was >4-8 hours. 19 It was an intriguing observation that donor dopamine ameliorated multiple dialysis requirement after transplantation independent from hypothermia in the multivariable regression analysis (Table 5) . Figure 3) . Due to the limited number of events and study subjects in the hypothermia group, we were unable to detect a titration effect below a CBT of 35.7°C. Third, sample size also limits the explanatory power regarding graft survival. On the basis of the present data, our T A B L E 6 Backward stepwise logistic regression of multiple dialysis requirement (>1 dialysis session) during the first week after transplantation. Insignificant terms were removed from the full models with a P > .10 study would approximately require a 2.5-fold higher number of study subjects for detection of a clinically meaningful 5% absolute reduction in allograft survival.
Data from controlled donor intervention trials are, in general, sparse.
The sparsity of such trials warrants the post-hoc analysis of already existing data. Donor intervention trials face the special feature that research does not take place in subjects who received the intervention.
Furthermore, the intervention is usually administered when the recipient
has not yet been selected. Due to time constraints of the transplantation procedure and to the broad geographic reach of organ allocation, it is almost not feasible to obtain informed consent from a recipient with the intention to withdraw a particular donor from the trial, in case the recipient decided not to give informed consent. Otherwise, if patients awaiting an offer were excluded from receiving the organ unless they had given consent for study participation, this would produce an unacceptable ethical dilemma. In the dopamine trial, the intervention was arguably low or minimal risk, and all donors were treated according to current standards of care with a fully approved drug. Therefore, the institutional review board decided to waive a requirement of written informed consent.
Future research in this field should ideally follow a consensus recommendation involving the transplant community, the ethical committees, and the supervisory authorities for guidance of ethical and safe intervention trials designed to test novel therapies in deceased donors.
In conclusion, the present study suggests that spontaneous donor CBT<36.0°C, as assessed by just a single temperature measurement 4-20 hours prior to procurement, is associated with reduced DGF after kidney transplantation. A lower CBT in the DBD correlates with lower serum creatinine levels and may reflect attenuated AKI after 
